跳至主要内容
临床试验/NL-OMON50113
NL-OMON50113撤回4 期

A strategy of bacterial eradication to prevent exacerbations of COPD in the frequent exacerbator phenotype population (GOAL study), a prospective randomized controlled pilot study - The GOAL Study

Amphia Ziekenhuis0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - COPD patients, who were 18 years or older, hospitalized with an exacerbation
  • which they need to receive corticosteroids and antibiotic treatment.
  • - COPD patients with 1 or more exacerbations in the previous year before
  • for which they received steroids and/or antibiotic treatment.
  • - FEV1 less than 80% of predicted, FEV1 to FVC ratio < 0.7 and a history of
  • - Procalcitonin value >0.25 µg/L or CRP value > 50 mg/L

排除标准

  • - History of fluoroquinolon hypersensitivity or adverse reaction to inhaled
  • fluoroquinolones
  • - A history of other significant respiratory diseases (e.g. asthma, cystic
  • fibrosis), the
  • presence of bronchiectasis assessed by computed tomography (CT), pregnant or
  • lactating women, malignancy of any kind for which the subject received
  • treatment or was being monitored as part of follow up after treatment,

研究者

发起方
Amphia Ziekenhuis

相似试验